Conclusion
This risk-stratification model can facilitate the early prediction of
disease progression in asymptomatic, severe presymptomatic, and
non-severe presymptomatic patients based on 10 laboratory indicators and
thereby help make appropriate clinical decisions and optimize the use of
limited resources. This model and the 10 laboratory indicators can help
improve the clinical management of COVID-19 patients who are at
different stages of disease evolution.